Replies to post #165513 on Biotech Values

[biopearl]

Nuere, blade and others, quite an interesting week for Geron. More background from at least two patients who seem credible posters on blogs, both with spouses in the program for MF at Mayo and both apparently doing well, one w CR and one with CI. The harsh criticism levied on our interpretation of ASH data seems to have been unfounded as objections re spleen effect, night sweats etc seem to have been laid to rest with NO mea culpas from the hubristic unrepentant perpetrators. Resolution of bone marrow effects in PR and CR patients said to be durable. We should have data from a full forty patients soon. Best wishes, bp